Plug Pulled on Constipation Drug
A drug commonly used to treat constipation in those with Irritable Bowel Syndrome (IBS) was recently pulled from the market because a recent review of studies on the drug indicated an unacceptable risk of heart attack, stroke and death from drug usage. According to the HealthDay report, specialists who treat IBS were lamenting this state of affairs, stating that many patients using the drug have found relief from IBS, which can be such a disabling disorder.
I have personal experience with IBS; I feel for those suffering. I wonder how many of these patients tried natural approaches to dealing with IBS before resorting to a drug with such dangerous side effects? I wonder how many doctors provided information about the natural approaches to dealing with IBS? Approaches that offer side benefits only…and no side effects. When drugs are necessary, I’m as thankful as the next person that they’re available. But I hope the realization is expanding that we should do all we can to work with our bodies and enable them to function properly before we resort to drugs (all of which have negative side effects).
The other noteworthy thing about this news is that the drug is being removed because its risk-to-benefit profile is no longer favorable, according to the FDA. This conclusion resulted from a review of the available studies, undertaken by the maker of the drug at the request of a Swiss health agency. I admit I don’t know the details of the FDA drug approval process, but I do find it worrisome that this agency approved the same drug earlier. Either all the studies now reviewed were not available at the time of approval or they were available, but not found to be prohibitive. Either way, I don’t feel very protected, do you?